Inovio Pharmaceuticals earnings were -$87.8M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest INO earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$23.5M, up 19.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, INO reported annual earnings of -$107.3M, with -20.6% growth.
Inovio Pharmaceuticals Earnings Reports & History FAQ
What were Inovio Pharmaceuticals's earnings last quarter?
Inovio Pharmaceuticals (NASDAQ: INO) reported Q2 2025 earnings per share (EPS) of -$0.61, up 48.74% year over year. Total INO earnings for the quarter were -$23.52 million. In the same quarter last year, Inovio Pharmaceuticals's earnings per share (EPS) was -$1.19.
Is Inovio Pharmaceuticals profitable or losing money?
As of the last Inovio Pharmaceuticals earnings report, Inovio Pharmaceuticals is currently losing money. Inovio Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$87.76 million, a 27.85% decrease year over year.
What was INO's earnings growth in the past year?
As of Inovio Pharmaceuticals's earnings date in Q3 2025, Inovio Pharmaceuticals's earnings has grown year over year. INO earnings in the past year totalled -$87.76 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.